Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
JNJ:NYQ since
Innovalens BVDeal completed15 Feb 201915 Feb 2019Deal completed3.16%--
Ci:z Holdings Co LtdAnnounced23 Oct 201823 Oct 2018Announced-0.09%1.33bn
CIC CorpAnnounced23 Oct 201823 Oct 2018Announced-0.09%711.33m
EIT Emerging Implant Technologies GmbHAnnounced31 Aug 201831 Aug 2018Announced2.67%--
Actelion Pharmaceuticals Korea LtdDeal completed23 Mar 201823 Mar 2018Deal completed8.77%5.49m
Data delayed at least 15 minutes, as of Mar 19 2019 18:45 BST.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.